Ultimele actualizari :
19/11/2024
Bibliografie   Bibliografie 3981  
tip : ziar
Internet legătură într- : http://dx.doi.org/10.1136/ejhpharm-2016-000980

Echipe de cercetare : Wuhan - Wuhan University, College of Pharmacy
Autor : He G, Zeng F, Lei K, Xia S, Deng L, Zhang C, Liu D.
titlu : Compatibility of dexamethasone sodium phosphate with 5-HT3 receptor antagonists in infusion solutions: a comprehensive study
Référence : EJHP ;24:162?166 2017

Nivelul dovezii : 
Nivel de evidență A+
stabilitatea fizică : 
Examinare vizuala Numararea particulelor 
Stabilitate chimică : 
Cromatografia de lichide de inalta performanta cu detector in ultraviolet
Stabilitate definită ca si 95% din concentrația inițială
alte metode : 
Comentarii : 
Produși de degradare nu au fost observati în condiții reale

Listele
InjectabilAzasetron Antiemetic
Compatibil 0.2 mg/ml + InjectabilDexamethasone sodium phosphate 0.1 & 0.2 mg/ml + clorura de sodiu 0,9%
InjectabilDexamethasone sodium phosphate Antiinflamator
Compatibil 0.1 & 0.2 mg/ml + InjectabilAzasetron 0.2 mg/ml + clorura de sodiu 0,9%
Compatibil 0.1 & 0.2 mg/ml + InjectabilDolasetron mesylate 0.05 mg/ml + clorura de sodiu 0,9%
Compatibil 0.1 & 0.2 mg/ml + InjectabilDolasetron mesylate 1 mg/ml + Glucoza 5%
Compatibil 0.1 & 0.2 mg/ml + InjectabilOndansetron hydrochloride 0.08 mg/ml + NaCl 0,9% sau Glucoza 5%
Compatibil 0.1 & 0.2 mg/ml + InjectabilPalonosetron hydrochloride 2.5 µg/ml + NaCl 0,9% sau Glucoza 5%
Compatibil 0.1 & 0.2 mg/ml + InjectabilRamosetron 3 µg/ml + NaCl 0,9% sau Glucoza 5%
InjectabilDolasetron mesylate Antiemetic
Compatibil 0.05 mg/ml + InjectabilDexamethasone sodium phosphate 0.1 & 0.2 mg/ml + clorura de sodiu 0,9%
Compatibil 1 mg/ml + InjectabilDexamethasone sodium phosphate 0.1 & 0.2 mg/ml + Glucoza 5%
InjectabilOndansetron hydrochloride Antiemetic
Compatibil 0.08 mg/ml + InjectabilDexamethasone sodium phosphate 0.1 & 0.2 mg/ml + NaCl 0,9% sau Glucoza 5%
InjectabilPalonosetron hydrochloride Antiemetic
Compatibil 2.5 µg/ml + InjectabilDexamethasone sodium phosphate 0.1 & 0.2 mg/ml + NaCl 0,9% sau Glucoza 5%
InjectabilRamosetron Antiemetic
Compatibil 3 µg/ml + InjectabilDexamethasone sodium phosphate 0.1 & 0.2 mg/ml + NaCl 0,9% sau Glucoza 5%
InjectabilTropisetron hydrochloride Antiemetic
Stabilitatea in amestec
poliolefine NaCl 0,9% sau Glucoza 5% 23-27°C Lumina
Injectabil Dexamethasone sodium phosphate 0,1 mg/ml
Injectabil Ondansetron hydrochloride 0,08 mg/ml
48 Ora
poliolefine NaCl 0,9% sau Glucoza 5% 23-27°C Lumina
Injectabil Dexamethasone sodium phosphate 0,2 mg/ml
Injectabil Ondansetron hydrochloride 0,08 mg/ml
48 Ora
poliolefine NaCl 0,9% sau Glucoza 5% 23-27°C Lumina
Injectabil Dexamethasone sodium phosphate 0,2 mg/ml
Injectabil Palonosetron hydrochloride 2.5 µg/ml
48 Ora
poliolefine NaCl 0,9% sau Glucoza 5% 23-27°C Lumina
Injectabil Dexamethasone sodium phosphate 0,1 mg/ml
Injectabil Palonosetron hydrochloride 2.5 µg/ml
48 Ora
poliolefine NaCl 0,9% sau Glucoza 5% 23-27°C Lumina
Injectabil Ramosetron 3 µg/ml
Injectabil Dexamethasone sodium phosphate 0,1 mg/ml
48 Ora
poliolefine NaCl 0,9% sau Glucoza 5% 23-27°C Lumina
Injectabil Dexamethasone sodium phosphate 0.2 mg/ml
Injectabil Ramosetron 3 µg/ml
48 Ora
poliolefine clorura de sodiu 0,9% 23-27°C Lumina
Injectabil Dexamethasone sodium phosphate 0,2 mg/ml
Injectabil Tropisetron hydrochloride 0,05 mg/ml
48 Ora
poliolefine clorura de sodiu 0,9% 23-27°C Lumina
Injectabil Tropisetron hydrochloride 0,05 mg/ml
Injectabil Dexamethasone sodium phosphate 0,1 mg/ml
48 Ora
poliolefine clorura de sodiu 0,9% 23-27°C Lumina
Injectabil Dexamethasone sodium phosphate 0,1 mg/ml
Injectabil Dolasetron mesylate 1 mg/ml
48 Ora
poliolefine clorura de sodiu 0,9% 23-27°C Lumina
Injectabil Dexamethasone sodium phosphate 0,2 mg/ml
Injectabil Dolasetron mesylate 1 mg/ml
48 Ora
poliolefine clorura de sodiu 0,9% 23-27°C Lumina
Injectabil Azasetron 0,2 mg/ml
Injectabil Dexamethasone sodium phosphate 0,1 mg/ml
48 Ora
poliolefine clorura de sodiu 0,9% 23-27°C Lumina
Injectabil Dexamethasone sodium phosphate 0,2 mg/ml
Injectabil Azasetron 0,2 mg/ml
48 Ora

  Mentions Légales